Paraguay vs Togo: The number of people with susceptibility test result for rifampicin
Paraguay
92.7
in 2021
Togo
92.42
in 2021
Paraguay rank
60th
Togo rank
61st
The number of people with susceptibility test result for rifampicin over time
- Paraguay
- Togo
How they compare
Paraguay currently reports 92.7 against 92.42 in Togo, a difference of 0.28.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Paraguay ahead.
Paraguay ranks 60th and Togo ranks 61st of 146 countries.
Across the 2 decades both report, Paraguay averaged higher in 1 and Togo in 1.
Head to head by decade
| Decade | Paraguay | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 42.23 | 36.81 | 5.42 | Paraguay |
| 2020s | 74.59 | 90.74 | 16.16 | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Paraguay or Togo?
- Paraguay, at 92.7 against 92.42 in Togo as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Paraguay and Togo?
- 0.28, with Paraguay ahead.
- How many years of comparable data are there for Paraguay and Togo?
- 5 years are reported by both, from 2017 to 2021.
- How do Paraguay and Togo rank globally for the number of people with susceptibility test result for rifampicin?
- Paraguay ranks 60th and Togo ranks 61st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.